LOTEPREDNOL ETABONATE

Product NDC
0574-4135
11-digit product format
005744135
Labeler code
0574
Product ID
0574-4135_1c88bd5e-7e65-4cfe-b1d9-0894f4a4f82a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
loteprednol etabonate
Dosage form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Labeler
Padagis US LLC
Application
ANDA215204
Marketing category
ANDA
Marketing start
2026-01-12
Substance
LOTEPREDNOL ETABONATE
Active strength
5 mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215204-001LOTEPREDNOL ETABONATELOTEPREDNOL ETABONATE0.5%SUSPENSION/DROPS / OPHTHALMICAB2025-01-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A215204-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A215204-001LOTEPREDNOL ETABONATE0.5%SUSPENSION/DROPS / OPHTHALMICAB2025-01-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A215204-001LOTEPREDNOL ETABONATE0.5%SUSPENSION/DROPS / OPHTHALMICAB2025-01-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215204-001LOTEPREDNOL ETABONATE0.5%SUSPENSION/DROPS / OPHTHALMICAB2025-01-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08A215204-001LOTEPREDNOL ETABONATE0.5%SUSPENSION/DROPS / OPHTHALMICAB2025-01-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215204-001LOTEPREDNOL ETABONATE0.5%SUSPENSION/DROPS / OPHTHALMICAB2025-01-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215204-001LOTEPREDNOL ETABONATE0.5%SUSPENSION/DROPS / OPHTHALMICAB2025-01-29b8a1b40f171c…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215204-001LOTEPREDNOL ETABONATE0.5%SUSPENSION/DROPS / OPHTHALMICAB2025-01-29a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A215204-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A215204-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215204-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A215204-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215204-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215204-001AB1b8a1b40f171c…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215204-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
LOTEPREDNOL ETABONATE
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LOTEPREDNOL ETABONATE5 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
YEH1EZ96K6Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
311382Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
55ec893d-4955-4d2c-8b5b-84f462d23e02Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4f474382-f6ee-e00d-5df3-bba50cddfd89Product name520251114
64ba4d79-5363-eefc-3390-ee5d2a50a350Product name320250304
100e83dc-ec8c-9e2e-76d2-5112415ec972Product name320241008
4300453c-d545-46d1-b115-18b12b4ccf79Product name120210525
3f316f1c-2561-47c9-9865-ba2be69e0b3eProduct name120190614
f1ee2aaf-88da-4841-948b-7d3a6af14e35Product name120181206
aa1cd319-ece7-51f7-3a9d-52a64f5f4e81Product name120140508
b5c5cd73-a27b-5e41-bd36-3de9471473cdProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0574-4135-05LOTEPREDNOL ETABONATE1 in 1 CARTONSUSPENSION/ DROPS12
0574-4135-05LOTEPREDNOL ETABONATE5 mL in 1 BOTTLE, DROPPERSUSPENSION/ DROPS52
0574-4135-10LOTEPREDNOL ETABONATE1 in 1 CARTONSUSPENSION/ DROPS12
0574-4135-10LOTEPREDNOL ETABONATE10 mL in 1 BOTTLE, DROPPERSUSPENSION/ DROPS102
0574-4135-15LOTEPREDNOL ETABONATE1 in 1 CARTONSUSPENSION/ DROPS12
0574-4135-15LOTEPREDNOL ETABONATE15 mL in 1 BOTTLE, DROPPERSUSPENSION/ DROPS152

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0574-4135-05ML - Milliliter0574-4135ca0fd734-31f5-4895-8636-b9be9e293f0912026-01-08
0574-4135-10ML - Milliliter0574-413544891b33-8412-49a8-8351-6bc59018da6212026-01-08
0574-4135-15ML - Milliliter0574-413544deca5d-8723-4e8a-bc92-49109fc2144212026-01-08

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LOTEPREDNOL ETABONATELOTEPREDNOL ETABONATEPadagis US LLC55ec893d-4955-4d2c-8b5b-84f462d23e022024-04-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215204
application number: ANDA215204
ndc (product): 0574-4135

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
311382loteprednol etabonate 0.5 % Ophthalmic SuspensionPSN55ec893d-4955-4d2c-8b5b-84f462d23e022
311382loteprednol etabonate 5 MG/ML Ophthalmic SuspensionSCD55ec893d-4955-4d2c-8b5b-84f462d23e022
311382loteprednol etabonate 0.5 % Ophthalmic SuspensionSY55ec893d-4955-4d2c-8b5b-84f462d23e022

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0574-4135-05005744135051 BOTTLE, DROPPER in 1 CARTON (0574-4135-05) / 5 mL in 1 BOTTLE, DROPPER2026-01-12NoNoCurrent
0574-4135-10005744135101 BOTTLE, DROPPER in 1 CARTON (0574-4135-10) / 10 mL in 1 BOTTLE, DROPPER2026-01-12NoNoCurrent
0574-4135-15005744135151 BOTTLE, DROPPER in 1 CARTON (0574-4135-15) / 15 mL in 1 BOTTLE, DROPPER2026-01-12NoNoCurrent